Revok50 Best Injectable Hyaluronic Acid
Revok50 is a sterile gel syringe designed for intradermal injections. Revok50 is hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
Revok50 Best Injectable Hyaluronic Acid
Revok50 is a sterile gel syringe designed for intradermal injections. Revok50 is hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
Revok50 - Intensive Biostimulation
50mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI) per syringe make Revok50 ® a next-generation skin booster.
HA + A.As = Hydrating – Filling – Antiaging
A unique formulation consists of stabilized hyaluronic acid with a uniform double chain length of 2,200 KD and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl).
Restores elasticity and firmness to the skin thanks to the extremely high concentration of hyaluronic acid and the synergistic action of its biologically active eutrophic ingredients.
What Is Revok50?
Revok50 is medical device CE CLASS III Certificate in the form of Sterile Gel Intended for Intradermal Injections. Revok50® combines stabilized hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl). Revok50® is an optimal formulation for fibroblastic stimulation of collagen formation and maintenance of the extracellular matrix.
Revok50 Benefits
Revok50 – Intensive Integral Biostimulation.
Revok50 stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it and delays cell apoptosis and tissue aging. Revoke50 exerts an anti-inflammatory and repairing action on connective tissue and it has less susceptibility to endogenous hyaluronidase thanks to its high molecular weight, resulting in a longer duration of treatment effects.
- Due to high molecular weight, revok50 is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
Revok50 Composition
HYALURONIC ACID + AMINO ACIDS
Revok50® contains 50 mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI). It is a concentration 2.5 times higher than other products on the market.
HYALURONIC ACID AND OUR SKIN
The skin’s native hyaluronic acid is mainly made up of chains similar to those in the Revok50® composition. Non-crosslinked hyaluronic acid rapidly undergoes enzymatic degradation and breaks down into larger chains. In Revok50® this process is much slower thanks to the use of 2,200 kDa hyaluronic acid chains, which produce hydrogen bonds in an electrochemical process that stabilize the structure (ionic bonds between chains).
Revok50 Therapeutic Uses
MESOTHERAPY: FACE, NECK, DECOLLETE, ARMS AND HANDS
Injection protocol:
Superficial dermis injection – medium
30G 4mm needle.
Multipuncture technique. Angle < 15º:
* Papule (recommended separation between papules 5 – 10 mm.)
* Backtrace
Injection volume 0.01 – 0.02 ml. per point.
Treatment interval: one monthly session for three months (three sessions).
Compatible with a mesotherapy gun, it stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it.
DOUBLE CROWN LIFT (DCL TECHNIQUE)
The Double Crown Lift (DCL) technique has been exclusively developed by THR Medical Products by Dr. JR Vázquez.
The technique is based on anchoring the superficial facial retention ligaments and the lines of skin tension.
Injection protocol:
- Deep dermis injection
- 30G needle (4 – 6 mm.) or 27/25G cannula
- Papula point by point technique.
- Injection angle >45º
- Injection volume 0.1 ml. per point (one 2 ml syringe per session).
- Treatment interval: one session per month for 3 months (three sessions).
- A 2 ml Revok50® syringe is used in each session.
Revok50 Indications
Revok50 can treat skin dehydration
Repair of injuries caused by environmental agents such as UV radiation and pollution.
Connective tissue lesions such as stretch marks, scars and other dystrophies.
Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
Fine and medium wrinkles
Clinically Proven
Revok50 Training Workshop
It sounds like the Revok50 training workshop was a successful event that brought together a diverse group of professionals in the medical and aesthetic field. The workshop aimed to provide attendees with a deeper understanding of the Revok50 product and its applications
Redo Marketing Blogs
Revok50 Training
Revok50 Intensive Biostimulation Double Crown Lift Technique Training Workshop attended by doctors and aestheticians from Indonesia and Malaysia to learn more about the skin booster Revok50 injectable Hyaluronic Acid organised by Redo Marketing and Redo Marketing Indonesia.
Dermaceutic Workshop
Dermaceutic Workshop : New Innovative Treatment For Acne & Post Inflammatory Hyperpigmentation Date : 27 June 2023 Avenue : EQ Kuala Lumpur Equatorial Plaza Speaker : Dr. Mukta Sachdev, Medical Director of MS Clinical Research
PRP Workshop
PRP Treatment : Great PRP Workshop 2022 PRP Injection Technique For Knee Such a great PRP Workshop led by the astounding expertise and speaker that was attended by doctors and medical practitioners. Good experience of learning knowledgeable information about PRP for knees.
Cryopen Training
CRYOPEN WORKSHOP 2019 : INTERVIEW DATE : 23 October 2019 VENUE : Redo Marketing Headquarter, Shah Alam. TRAINER : Nicolas Lorey, International Sales Manager of Cryopen.
Revok50 Indications
Revoke50 can treat skin dehydration
Repair of injuries caused by environmental agents such as UV radiation and pollution.
Connective tissue lesions such as stretch marks, scars and other dystrophies.
Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
Fine and medium wrinkles
Revok50 Indications
Revoke50 can treat skin dehydration
Repair of injuries caused by environmental agents such as UV radiation and pollution.
Connective tissue lesions such as stretch marks, scars and other dystrophies.
Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
Fine and medium wrinkles
Revok50 Therapeutic Uses
MESOTHERAPY: FACE, NECK, DECOLLETE, ARMS AND HANDS
Injection protocol:
Superficial dermis injection – medium
30G 4mm needle.
Multipuncture technique. Angle < 15º:
* Papule (recommended separation between papules 5 – 10 mm.)
* Backtrace
Injection volume 0.01 – 0.02 ml. per point.
Treatment interval: one monthly session for three months (three sessions).
Compatible with a mesotherapy gun, it stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it.
DOUBLE CROWN LIFT (DCL TECHNIQUE)
The Double Crown Lift (DCL) technique has been exclusively developed by THR Medical Products by Dr. JR Vázquez.
The technique is based on anchoring the superficial facial retention ligaments and the lines of skin tension.
Injection protocol:
- Deep dermis injection
- 30G needle (4 – 6 mm.) or 27/25G cannula
- Papula point by point technique.
- Injection angle >45º
- Injection volume 0.1 ml. per point (one 2 ml syringe per session).
- Treatment interval: one session per month for 3 months (three sessions).
- A 2 ml Revok50® syringe is used in each session.
Revok50 Therapeutic Uses
MESOTHERAPY: FACE, NECK, DECOLLETE, ARMS AND HANDS
Injection protocol:
Superficial dermis injection – medium
30G 4mm needle.
Multipuncture technique. Angle < 15º:
* Papule (recommended separation between papules 5 – 10 mm.)
* Backtrace
Injection volume 0.01 – 0.02 ml. per point.
Treatment interval: one monthly session for three months (three sessions).
Compatible with a mesotherapy gun, it stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it.
DOUBLE CROWN LIFT (DCL TECHNIQUE)
The Double Crown Lift (DCL) technique has been exclusively developed by THR Medical Products by Dr. JR Vázquez.
The technique is based on anchoring the superficial facial retention ligaments and the lines of skin tension.
Injection protocol:
- Deep dermis injection
- 30G needle (4 – 6 mm.) or 27/25G cannula
- Papula point by point technique.
- Injection angle >45º
- Injection volume 0.1 ml. per point (one 2 ml syringe per session).
- Treatment interval: one session per month for 3 months (three sessions).
- A 2 ml Revok50® syringe is used in each session.
Revok50 Composition
HYALURONIC ACID + AMINO ACIDS
Revok50® contains 50 mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI). It is a concentration 2.5 times higher than other products on the market.
HYALURONIC ACID AND OUR SKIN
The skin’s native hyaluronic acid is mainly made up of chains similar to those in the Revok50® composition. Non-crosslinked hyaluronic acid rapidly undergoes enzymatic degradation and breaks down into larger chains. In Revok50® this process is much slower thanks to the use of 2,200 kDa hyaluronic acid chains, which produce hydrogen bonds in an electrochemical process that stabilize the structure (ionic bonds between chains).
Revok50 Composition
HYALURONIC ACID + AMINO ACIDS
Revok50® contains 50 mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI). It is a concentration 2.5 times higher than other products on the market.
HYALURONIC ACID AND OUR SKIN
The skin’s native hyaluronic acid is mainly made up of chains similar to those in the Revok50® composition. Non-crosslinked hyaluronic acid rapidly undergoes enzymatic degradation and breaks down into larger chains. In Revok50® this process is much slower thanks to the use of 2,200 kDa hyaluronic acid chains, which produce hydrogen bonds in an electrochemical process that stabilize the structure (ionic bonds between chains).
Revok50 Benefits
Revok50 – Intensive Integral Biostimulation.
Revok50 stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it and delays cell apoptosis and tissue aging. Revoke50 exerts an anti-inflammatory and repairing action on connective tissue and it has less susceptibility to endogenous hyaluronidase thanks to its high molecular weight, resulting in a longer duration of treatment effects.
- Due to high molecular weight, revok50 is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
Revok50 Benefits
Revok50 – Intensive Integral Biostimulation.
Revok50 stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it and delays cell apoptosis and tissue aging. Revoke50 exerts an anti-inflammatory and repairing action on connective tissue and it has less susceptibility to endogenous hyaluronidase thanks to its high molecular weight, resulting in a longer duration of treatment effects.
- Due to high molecular weight, revok50 is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
What Is Revok50?
Revok50 is medical device CE CLASS III Certificate in the form of Sterile Gel Intended for Intradermal Injections. Revok50® combines stabilized hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl). Revok50® is an optimal formulation for fibroblastic stimulation of collagen formation and maintenance of the extracellular matrix.
What Is Revok50?
Revok50 is medical device CE CLASS III Certificate in the form of Sterile Gel Intended for Intradermal Injections. Revok50® combines stabilized hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl). Revok50® is an optimal formulation for fibroblastic stimulation of collagen formation and maintenance of the extracellular matrix.
Revok50 Intra-Dermal Biotech HA
Revok50 Intra-Dermal Biotech HA
Revok50 Intra-Dermal Biotech HA
Revok50 Intra-Dermal Biotech HA
Revok50 Intra-Dermal Biotech HA
Revok50 Intra-Dermal Biotech HA
Revok50 Intra-Dermal Biotech HA
Revok50 Intra-Dermal Biotech HA
A sterile gel syringe called Revok50 is designed for intradermal injections. Hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
A sterile gel syringe called Revok50 is designed for intradermal injections. Hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
A sterile gel syringe called Revok50 is designed for intradermal injections. Hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
A sterile gel syringe called Revok50 is designed for intradermal injections. Hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
A sterile gel syringe called Revok50 is designed for intradermal injections. Hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
A sterile gel syringe called Revok50 is designed for intradermal injections. Hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
A sterile gel syringe called Revok50 is designed for intradermal injections. Hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
A sterile gel syringe called Revok50 is designed for intradermal injections. Hyaluronic acid that has been stabilized and has a uniform double chain length of 2,200 kDa is combined with L-proline, L-hydroxyproline, glycine, and L-lysine HCl amino acids to create this product. It’s formula has an anti-ageing effect by promoting the stimulation and repair of the skin’s connective tissue and reversing trophic skin changes including wrinkles, scars, stretch marks, etc.
Benefits
Benefits
Benefits
Benefits
Benefits
Benefits
Benefits
Benefits
- Due to high molecular weight, it is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
- Due to high molecular weight, it is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
- Due to high molecular weight, it is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
- Due to high molecular weight, it is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
- Due to high molecular weight, it is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
- Due to high molecular weight, it is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
- Due to high molecular weight, it is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
- Due to high molecular weight, it is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
- By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
- This injectable HA is 2.5 times more concentrated than other products on the market.
- It delays cell apoptosis and tissue ageing.
- Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.
Indications
Indications
Indications
Indications
Indications
Indications
Indications
Indications
- Skin Dehydration
- Repair of injuries caused by environmental agents such as UV radiation and pollution.
- Connective tissue lesions such as stretch marks, scars and other dystrophies.
- Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
- Fine and medium wrinkles
- Skin Dehydration
- Repair of injuries caused by environmental agents such as UV radiation and pollution.
- Connective tissue lesions such as stretch marks, scars and other dystrophies.
- Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
- Fine and medium wrinkles
- Skin Dehydration
- Repair of injuries caused by environmental agents such as UV radiation and pollution.
- Connective tissue lesions such as stretch marks, scars and other dystrophies.
- Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
- Fine and medium wrinkles
- Skin Dehydration
- Repair of injuries caused by environmental agents such as UV radiation and pollution.
- Connective tissue lesions such as stretch marks, scars and other dystrophies.
- Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
- Fine and medium wrinkles
- Skin Dehydration
- Repair of injuries caused by environmental agents such as UV radiation and pollution.
- Connective tissue lesions such as stretch marks, scars and other dystrophies.
- Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
- Fine and medium wrinkles
- Skin Dehydration
- Repair of injuries caused by environmental agents such as UV radiation and pollution.
- Connective tissue lesions such as stretch marks, scars and other dystrophies.
- Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
- Fine and medium wrinkles
- Skin Dehydration
- Repair of injuries caused by environmental agents such as UV radiation and pollution.
- Connective tissue lesions such as stretch marks, scars and other dystrophies.
- Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
- Fine and medium wrinkles
- Skin Dehydration
- Repair of injuries caused by environmental agents such as UV radiation and pollution.
- Connective tissue lesions such as stretch marks, scars and other dystrophies.
- Synergism with other aesthetic treatments such as fillers, lasers, microneedling.
- Fine and medium wrinkles